Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Poly A × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Radiation Injuries 1

Interventions

Paclitaxel 251 Cisplatin 225 Gemcitabine 223 Carboplatin 216 Cyclophosphamide 198 Radiotherapy 192 Irinotecan 158 Bevacizumab 148 pembrolizumab 145 Docetaxel 145 Capecitabine 128 Nivolumab 121 Fluorouracil 114 Dexamethasone 110 Bortezomib 105 Erlotinib Hydrochloride 104 Oxaliplatin 101 Cytarabine 101 Sorafenib 100 Temozolomide 94 Filgrastim 93 Doxorubicin 93 Leucovorin 92 Etoposide 91 Rituximab 90 Lenalidomide 86 Everolimus 83 Pemetrexed 75 Ipilimumab 74 fludarabine phosphate 73

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡